“PD-1 Inhibitors in Recurrent or Metastatic Oral Squamous Cell Carcinoma: Clinical Evidence, Patient Selection, and Immune-Related Toxicities” (2026) Journal of Oral Health and Dental Therapeutics, 1(1), pp. 27–31. doi:10.68041/johdt.v1i1/06.